Sep 11, 2020 | False Claims Act, Government Investigations
Even throughout the COVID-19 pandemic, the federal False Claims Act (FCA) has remained one of the federal government’s top tools to investigate and punish alleged fraud, waste, and abuse in relation to federal programs, particularly federal healthcare programs. In...
Aug 31, 2020 | False Claims Act
The Georgia Court of Appeals recently ruled on a case involving interpretation of the Georgia Taxpayer Protection False Claims Act (“TPFCA”), O.C.G.A. §23-3-120, et seq., which has not been the subject of many court opinions. The TPFCA authorizes the State of Georgia...
Aug 31, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid, White Collar Crime
The federal Anti-Kickback Statute (AKS), at its core, prohibits offering, paying, soliciting, or receiving any remuneration in exchange for federal healthcare program referrals. AKS violations carry potential criminal penalties, as well as civil and administrative...
Aug 4, 2020 | False Claims Act, Government Investigations
On July 30, 2020, United States Senator Charles Grassley announced that he intends to introduce legislation which would strengthen the federal False Claims Act (FCA). Grassley indicated that his proposed legislation would, at least in part, specifically address the...
Jul 6, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid
On June 26, 2020, the Eleventh Circuit Court of Appeals reinstated part of a $348 million verdict awarded pursuant to the False Claims Act (FCA). The court also held that a qui tam plaintiff may have standing to bring an FCA claim even after entering into a litigation...
Jul 2, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid
On July 1, 2020, the U.S. Department of Justice (“DOJ”) announced two separate settlements with Novartis Pharmaceuticals Corporation (“Novartis”), totaling more than $729 million, involving allegations that Novartis paid kickbacks to doctors and patients. In the first...
